North America Albendazole and Lvermectin Market by End-User, by Applications, by Type, by Deployment & by Technology 2032
North America Albendazole and Lvermectin Market was valued at USD 0.2 Billion in 2022 and is projected to reach USD 0.3 Billion by 2030, growing at a CAGR of 4.5% from 2024 to 2030. Albendazole and ivermectin, two widely used antiparasitic drugs, have become essential in treating